Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-14

Clinical Trial Update: The Effect of Albumin Value, HALP Score, and LCR Value on Predicting Survival and Recurrence in Patients With Pancreatic Adenocarcinoma

View source ↗

Summary

A completed clinical trial update examining whether albumin levels, HALP score, and LCR value can predict survival and recurrence in pancreatic cancer patients,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ege University | Conditions: Pancreatic Neoplasms, Pancreas Cancer | Status: COMPLETED